10/29/2015 - 5:03pm

Forbes is reporting that CVS and Express Scripts have cut ties with Valeant Pharmaceuticals’ specialty pharmacy Philidor Rx amid investigations into the company’s business practices. “In accordance with CVS/caremark’s standard auditing protocols, over the last several weeks we have been monitoring and reviewing the results of recent audits of Philidor’s practices,” CVS said in a statement. ”Based on the findings from those activities, we have terminated Philidor for noncompliance with the terms of its provider agreement.” (Forbes)

10/29/2015 - 10:35am

McKesson's North America pharmaceutical distribution and services revenues were $40.6 billion for the quarter, up 16% on a reported basis and 17% on a constant currency basis. 

10/28/2015 - 1:32pm

Amgen announced Wednesday that it had received approval from the Food and Drug Administration for Imlygic (talimogene laherparepvec) for injection.

10/26/2015 - 12:32pm

The drug is the first to be approved specifically for unresectable or metastatic liposarcoma, the company said. 

10/26/2015 - 12:00pm

Diplomat Pharmacy released a series of videos developed over the past year, each taken to tell the personal stories in specialty pharmacy.

10/22/2015 - 3:44pm

Merrimack Pharmaceuticals’ new pancreatic cancer drug was approved by the FDA Thursday. 

10/20/2015 - 11:21am

The PADSP has also launched a website, DrugProtections.org, that explains the REMS program to patients and lists medication that are currently marketed with a REMS.

10/16/2015 - 3:58pm

The company, which has 266 employees and has a 40,000-sq. ft. prescription and order intake department in addition to a laboratory and pharmacy dispensary, was honored for its growth in the past few years. 

10/16/2015 - 10:09am

No area of pharmacy is growing faster than specialty drugs.